PA
DHT icon

PharVision Advisers’s DHT Holdings DHT Stock Holding History

PharVision Advisers’s Portfolio DHT Stock Details DHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,597
Closed -$337K – 253
2025
Q4 		$337K Buy
27,597
+3,009
+12% +$37.9K 0.17% 216
2025
Q3 		$294K Buy
24,588
+7,771
+46% +$90.1K 0.17% 233
2025
Q2 		$182K Buy
+16,817
New +$185K 0.26% 214

Other funds holding DHT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HP
Hosking Partners London, United Kingdom $2.79B AUM 58.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PharVision Advisers's DHT Position: Q1 2026 in Review

PharVision Advisers sold out of DHT Holdings (DHT) in Q1 2026, closing a stake of 27,597 shares — an estimated $337K sold.

PharVision Advisers first reported a position in DHT in Q2 2025 and held it in 3 quarters. The position peaked at $337K in Q4 2025. 289 funds tracked by Wall St. Rank hold DHT as of Q1 2026.

  • PharVision Advisers reported no remaining DHT Holdings position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 27,597 DHT Holdings shares in Q1 2026, an estimated $337K.
  • PharVision Advisers first reported a position in DHT Holdings in Q2 2025 and held it in 3 quarters.
  • PharVision Advisers's DHT Holdings position peaked at $337K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held DHT Holdings as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.